CHEMOTHERAPY-INDUCED THROMBOCYTOPENIA
Clinical trials for CHEMOTHERAPY-INDUCED THROMBOCYTOPENIA explained in plain language.
Never miss a new study
Get alerted when new CHEMOTHERAPY-INDUCED THROMBOCYTOPENIA trials appear
Sign up with your email to follow new studies for CHEMOTHERAPY-INDUCED THROMBOCYTOPENIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope to stop chemotherapy delays for lung, breast, and ovarian cancer patients
Disease control OngoingThis study is testing whether a drug called romiplostim can help cancer patients avoid delays or reductions in their chemotherapy. It focuses on patients with lung, breast, or ovarian cancer who develop low platelet counts from chemo, a common side effect. The goal is to see if t…
Matched conditions: CHEMOTHERAPY-INDUCED THROMBOCYTOPENIA
Phase: PHASE3 • Sponsor: Amgen • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
New hope to keep cancer treatment on track: drug trial targets Chemotherapy's dangerous side effect
Disease control OngoingThis study is testing if a drug called avatrombopag can help patients with gastrointestinal cancers who develop persistently low platelet counts from their chemotherapy. Low platelets can cause dangerous bleeding and force doctors to delay or reduce chemotherapy doses. About 60 p…
Matched conditions: CHEMOTHERAPY-INDUCED THROMBOCYTOPENIA
Phase: PHASE2 • Sponsor: Hanny Al-Samkari, MD • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC